Enfermedades olvidadas no son business para laboratorios pero matan a miles cada año

.www.stanford.edu/.../Leishmaniasis/cutaneous.htm





.www.stanford.edu/.../Leishmaniasis/cutaneous.htm

.





Seminal Workshop „ Brasilian-German Research Initiative on

Natural Products against Neglected

Diseases

”

Date: April 26 -29, 2011

Brazil is among the countries most strongly haunted by parasitic diseases caused by protozoan pathogens.

These infections severely affect the country’s public health and welfare. It is mainly the poor rural and

suburban population that suffers from diseases such as Chagas’ Disease and Leishmanioses. The former, e.g., is an acute threat for approximately 35 Millions of people with an estimated 600.000 new infections and 11.000

deaths per year world-wide, children being most frequently affected. Big pharmaceutical companies are still

not investing duly into the development of new safe and efficacious remedies. However, in the last decade,

non-profit research initiatives such as DNDi have brought new progress to this field. Not being able to develop

new therapeuticals from drug discovery to an approved medication on its own, academic research can yet play

an important role in this endeavor by performing basic research in the pre-clinical phases, i.e. discovery of new

active compounds, elucidation of new mechanisms and setup of new strategies by which the parasites may be

attacked. One important source in the search for new antiprotozoal compounds is nature itself.

Many highly

active natural products have been used in medicine, including treatment of protozoan infections such as

Malaria, for many centuries. Natural products are being investigated by many research groups also for their

Trypanosoma cruzi and various Leishmania  species, respectively).

The main

objective of the planned event is to bring together scientists from Brazil and Germany who are already working

in this field and intending to dedicate more of their research towards this endeavor. Natural Products Chemists

/ Medicinal plant researchers from both countries will meet biomedical and medical scientists working in the

fields of antiprotozoal testing as well as officials and researchers from non-profit organizations involved in the

development of new antiprotozoal therapies and field clinical studies.

Bringing together the right people with a broad spectrum of viewpoints focused on one common aim will

enable discussions between researchers working on the various aspects along the drug development line. The

meeting will be the starting point for new antiprotozoal research projects, and will thus initiate a truly

coordinated and focused multilateral effort towards this important goal.

The meeting will take place at the Westfälische Wilhelms-Universität Münster, where it will be held at the

Münster Castle (the main University building and seat of the Rectorate) in a suitable atmosphere for fruitful

scientific discussions and the making of future plans. The meeting will proceed over three days and consist of a

series of plenary and short lectures on the various relevant aspects, each followed by a sufficient amount of

time for thorough discussions, accompanied by “brainstorming sessions” as well as sufficient amount of time

for discussions in smaller groups and summarizing plenary discussions on each day. As a final outcome, a

proceedings book will be issued along with a common agenda and a declaration of aims and goals for the

planned initiative.

http://www.smh.de/i/content/Thomas_Schmidt.jpg

http://www.dbwti.de/veranstaltungskalender/app/webroot/files/104/Seminal%20Workshop_NaturalProductsAgainstNeglectedDiseases_Brazil_Germany_short_260111.pdf

[PDF]

Workshop Iniciativa de Pesquisas Brasil-Alemanha sobre Produtos ... - [ Traducir esta página ]